28 Understanding the molecular mechanism(s) of the role of IL-6R in gout, perhaps mediated by IL-6 signaling and/or a role in clonal hematopoiesis, will be important in evaluating the suitability of tocilizumab as a therapy in gout. This evidence concerns the gene IL6R and gout.